NAC1 modulates autoimmunity by suppressing regulatory T cell–mediated tolerance
Science Advances, 2022•science.org
We report here that nucleus accumbens–associated protein-1 (NAC1), a nuclear factor of
the Broad-complex, Tramtrack, Bric-a-brac/poxvirus and zinc finger (BTB/POZ) gene family,
is a negative regulator of FoxP3 in regulatory T cells (Tregs) and a critical determinant of
immune tolerance. Phenotypically, NAC1−/− mice showed substantial tolerance to the
induction of autoimmunity and generated a larger amount of CD4+ Tregs that exhibit a
higher metabolic profile and immune-suppressive activity, increased acetylation and …
the Broad-complex, Tramtrack, Bric-a-brac/poxvirus and zinc finger (BTB/POZ) gene family,
is a negative regulator of FoxP3 in regulatory T cells (Tregs) and a critical determinant of
immune tolerance. Phenotypically, NAC1−/− mice showed substantial tolerance to the
induction of autoimmunity and generated a larger amount of CD4+ Tregs that exhibit a
higher metabolic profile and immune-suppressive activity, increased acetylation and …
We report here that nucleus accumbens–associated protein-1 (NAC1), a nuclear factor of the Broad-complex, Tramtrack, Bric-a-brac/poxvirus and zinc finger (BTB/POZ) gene family, is a negative regulator of FoxP3 in regulatory T cells (Tregs) and a critical determinant of immune tolerance. Phenotypically, NAC1−/− mice showed substantial tolerance to the induction of autoimmunity and generated a larger amount of CD4+ Tregs that exhibit a higher metabolic profile and immune-suppressive activity, increased acetylation and expression of FoxP3, and slower turnover of this transcription factor. Treatment of Tregs with the proinflammatory cytokines interleukin-1β or tumor necrosis factor–α induced a robust up-regulation of NAC1 but evident down-regulation of FoxP3 as well as the acetylated FoxP3. These findings imply that NAC1 acts as a trigger of the immune response through destabilization of Tregs and suppression of tolerance induction, and targeting of NAC1 warrants further exploration as a potential tolerogenic strategy for treatment of autoimmune disorders.
AAAS
以上显示的是最相近的搜索结果。 查看全部搜索结果